PB-201

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NamePB-201
Drug Alias NamePF-4937319WI-0800PB-201PF-04937319
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPfizer Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPeg Bio Co Ltd
Inactive CompaniesPfizer Inc
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A